Viking Global Investors LP Amneal Pharmaceuticals, Inc. Transaction History

Viking Global Investors LP

  • $25.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$11.87 - $14.84 $27.9 Million - $34.9 Million
-2,353,204 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$13.09 - $21.49 $10.7 Million - $17.5 Million
815,629 Added 53.05%
2,353,204 $31.8 Million
Q3 2018

Nov 14, 2018
BUY
$16.4 - $24.27 $25.2 Million - $37.3 Million
1,537,575 New
1,537,575 $34.1 Million

Others Institutions Holding AMRX

# of Institutions
193
Shares Held
140M
Call Options Held
57K
Put Options Held
49K
View Full List

About Amneal Pharmaceuticals, Inc.

AMRX Quotes by TradingView
  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.32B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email